Predictors of all-cause mortality in patients with stable copd: Medical co-morbid conditions or high depressive symptoms

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 4, 2014, Pages 468-474

  Maters, Gemma A ^a   De Voogd, Jacob N ^a   Sanderman, Robbert ^a,b   Wempe, Johan B ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Co morbidity; Depression; Heart failure; Survival

Indexed keywords

CARBON DIOXIDE; LACTIC ACID; OXYGEN;

ADULT; AGE; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; BICYCLE ERGOMETRY; BODY MASS; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; EXERCISE; FAT FREE MASS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODERATE RENAL IMPAIRMENT; MORTALITY; MORTALITY RATE; NEOPLASM; OXYGEN CONSUMPTION; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROGNOSIS; RESIDUAL VOLUME; SEVERE RENAL IMPAIRMENT; SEX DIFFERENCE; SMOKING; SURVIVAL; SYMPTOM CHECKLIST 90; TOTAL LUNG CAPACITY; WORKLOAD; AGED; CAUSE OF DEATH; EXERCISE TOLERANCE; HEART FAILURE; OBESITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RISK FACTOR; SURVIVAL RATE;

ADIPOSITY; AGE FACTORS; AGED; CAUSE OF DEATH; COMORBIDITY; DEPRESSION; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SURVIVAL RATE;

EID: 84925884229     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.898026     Document Type: Article

References (47)

1. Chatila WM, Th omashow BM, Minai OA, Criner GJ, Make BJ. Co-morbidities in chronic obstructive pulmonary disease. Proc Am Th orac Soc 2008; 5(4):549–555.
2. Patel AR, Hurst JR. Extrapulmonary co-morbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 2011; 5(5):647–662.
3. Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, et al. Th e prevalence of clinically-relevant co-morbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med 2012; 12(26):567–574.
4. Anecchino C, Rossi E, Fanizza C, De Rosa M, Tognoni G, Romero M, et al. Prevalence of chronic obstructive pulmonary disease and pattern of co-morbidities in a general population. Int J Chron Obstruct Pulmon Dis 2007; 2(4):567–574.
5. Almagro P, Cabrera FJ, Diez J, Boixeda R, Ortiz B, Murio C, et al. Co-morbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD. Th e ESMI study. Chest 2012; 142(5):1126–1133.
6. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124(2):459–467.
7. Almagro P, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, Heredia JL, et al. Mortality after hospitalization for COPD. Chest 2002; 121(5):1441–1448.
8. Holguin F, Folch E, Redd SC, Mannino DM. Co-morbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128(4):2005–2011.
9. Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003; 163(10):1180–1186.
10. Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10(12):2794–2800.
11. Marti S, Munoz X, Rios J, Morell F, Ferrer J. Body weight and co-morbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 2006; 27(4):689–696.
12. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(6):591–597.
13. Soler-Cataluna JJ, Sanchez-Sanchez L, Martinez-Garcia MA, Sanchez PR, Salcedo E, Navarro M. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest 2005; 128(4):2108–2115.
14. de Voogd JN, Wempe JB, Koeter GH, Postema K, van Sonderen E, Ranchor AV, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009; 135(3):619–625.
15. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Th orax 1992; 47(12):1019–1024.
16. Varray A, Prefaut C. Exercise capacity in patients with respiratory disease: procedure and results. Eur Resp Rev 1995; 5:51–58.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5):373–383.
18. Van Hemert B, Ormel J. Nederlandse versie van de Hospital Anxiety and Depression Scale (HADS); vragenlijst en regels voor scoring - Dutch version of the Hospital Anxiety and Depression Scale (HADS); questionnaire and scoring instructions. Leiden / Groningen: Vakgroep psychiatrie / Vakgroep gezondheidswetenschappen; 1993.
19. Zigmond AS, Snaith RP. Th e hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6):361–370.
20. Derogatis LR. SCL-90: administration, scoring and procedures manual-I for the R(evised) version. Baltimore: Johns Hopkins University School of Medicine, Clinical Research Unit; 1977.
21. Arrindell WA, Ettema JHM. SCL-90: Handleiding voor een multidimensionele psychopathologie-indicator-SCL-90: Manual for a multifaceted measure of psychopathology. Lisse: Swets & Zeitlinger; 2003.
22. Wagena EJ, Arrindell WA, Wouters EF, van Schayck CP. Are patients with COPD psychologically distressed? Eur Respir J 2005; 26(2):242–248.
23. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of co-morbidities. Eur Respir J 2006; 28(6):1245–1257.
24. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto- Plata V, et al. Co-morbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186(2):155–161.
25. de Voogd JN, Wempe JB, Postema K, van Sonderen E, Ranchor AV, Coyne JC, et al. More evidence that depressive symptoms predict mortality in COPD patients: is type D personality an alternative explanation? Ann Behav Med 2009; 38(2):86–93.
26. Moberg M, Vestbo J, Martinez G, Williams JE, Ladelund S, Lange P, et al. Validation of the i-BODE Index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation. COPD 2013 epub ahead of print.
27. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume–reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003 05/22; 2014/01; 348(21):2059–2073.
28. Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010; 182(3):325–331.
29. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of co-morbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128(4):2099–2107.
30. Noteboom B, Jenkins S, Maiorana A, Cecins N, Ng C, Hill K. Co-morbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation. J Cardiopulm Rehabil Prev 2014; 34(1):75–79.
31. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? Th e potential role of systemic infl ammation in chronic obstructive pulmonary disease. Circulation 2003; 107(11):1514–1519.
32. Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128(4):2068–2075.
33. Rutten FH, Moons KG, Cramer MM, Grobbee DE, Zuithoff N, Hoes AW. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005; 331(7529):1379.
34. Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D, et al. Unrecognised ventricular dysfunction in COPD. Eur Respir J 2012; 39(1):51–58.
35. Slenter RH, Sprooten RT, Kotz D, Wesseling G, Wouters EF, Rohde GG. Predictors of 1-year mortality at hospital admission for acute exacerbations of Chronic Obstructive Pulmonary Disease. Respiration 2012 Oct 2; 85(1):15–26.
36. Hoiseth AD, Omland T, Hagve TA, Brekke PH, Soyseth V. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD—a prospective cohort study. Respir Res 2012 Oct 29;13:97–99.
37. Medina AM, Marteles MS, Saiz EB, Martinez SS, Laiglesia FR, Rodriguez JA, et al. Prognostic utility of NT-proBNP in acute exacerbations of chronic pulmonary diseases. Eur J Intern Med 2011; 22(2):167–171.
38. Ringbaek T, Martinez G, Brondum E, Th ogersen J, Morgan M, Lange P. Shuttle walking test as predictor of survival in chronic obstructive pulmonary disease patients enrolled in a rehabilitation program. J Cardiopulm Rehabil Prev 2010; 30(6):409–414.
39. Williams JE, Green RH, Warrington V, Steiner MC, Morgan MD, Singh SJ. Development of the i-BODE: validation of the incremental shuttle walking test within the BODE index. Respir Med 2012; 106(3):390–396.
40. Arnardottir RH, Emtner M, Hedenstrom H, Larsson K, Boman G. Peak exercise capacity estimated from incremental shuttle walking test in patients with COPD: a methodological study. Respir Res 2006; 7:127.
41. Luxton N, Alison JA, Wu J, Mackey MG. Relationship between fi eld walking tests and incremental cycle ergometry in COPD. Respirology 2008; 13(6):856–862.
42. Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140(2):331–342.
43. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: fi ndings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173(1):79–83.
44. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82(1):53–59.
45. Nezu K, Kawaguchi T, Kimura M, Yasukawa M, Kushibe K, Taniguchi S, et al. Lung volume reduction surgery and nutritional status in patients with severe emphysema. Jpn J Th orac Cardiovasc Surg 2001; 49(9):552–556.
46. Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 2005; 34(5):491–496.
47. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: eff ect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167(1):60–67.